Michael Burry
MRNS icon

Michael Burry’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Michael Burry’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-625,000
Closed -$11.2M – 22
2021
Q2 		$11.2M Buy
625,000
+327,728
+110% +$5.27M 0.54% 17
2021
Q1 		$4.6M Buy
+297,272
New +$4.3M 0.34% 23

Other funds holding MRNS

LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VR Adviser
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Boxer Capital
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Suvretta Capital Management
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Michael Burry's MRNS Position: Q3 2021 in Review

Michael Burry sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2021, closing a stake of 625,000 shares — an estimated $11.2M sold.

Michael Burry first reported a position in MRNS in Q1 2021 and held it in 2 quarters. The position peaked at $11.2M in Q2 2021. 82 funds tracked by Wall St. Rank hold MRNS as of Q3 2021.

  • Michael Burry reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2021 after selling out during the quarter.
  • Michael Burry sold 625,000 Marinus Pharmaceuticals, Inc shares in Q3 2021, an estimated $11.2M.
  • Michael Burry first reported a position in Marinus Pharmaceuticals, Inc in Q1 2021 and held it in 2 quarters.
  • Michael Burry's Marinus Pharmaceuticals, Inc position peaked at $11.2M in Q2 2021.
  • 82 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2021.

Based on Scion Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.